Motivation: The analysis of gene expression data in its chromosomal context has been a recent
INTRODUCTION
In human tumors, gains as well as losses of genomic DNA occur commonly (Loeb & Christians, 1996) . The application of genome-wide analysis techniques such as chromosome painting, comparative genomic hybridization (CGH), and loss of heterozygosity have given insight into the extensive nature of this genomic instability occurring in tumors (Gray & Collins, 2000) . With the proliferation of gene expression microarray technologies and the availability of the human genome sequence, findings suggest that expression array data may be used to detect regions of amplification and deletion containing genes that influence tumor initiation and progression (Bayani et al., 2002; Beer et al., 2002; Godfried et al., 2002; Hyman et al., 2002; Kauraniemi et al., 2001; Miller et al., 2003; Pollack et al., 2002; Wolf et al., 2004) . As such, the identification of chromosomal regions of increased or decreased expression has recently been a fruitful area of cancer research, and the number of methods being put forth to study these phenomena is growing (Caron et al., 2001; Crawley & Furge, 2002; Husing et al., 2003; Kano et al., 2003; Pollack et al., 2002; Zhou et al., 2003) .
Generally, these methods utilize only the relative position of genes on an array-based gene map. This strategy implicitly assumes that the distances between the genes are fixed and constant, which further assumes that gene density is constant within and across chromosomes.
Due to the spatial nature of the mechanism of amplification, genes that occur closer to one another are more likely to be included in the same amplicon. Therefore, in the context of studying gene expression patterns to identify amplified genes, a method that accounts for variation in both the distance between consecutive genes and gene density is necessary. Further, the GC content of a region has been shown to have an influence on gene density (Bernardi, 2000) and has been shown to be associated with patterns of increased gene expression (Godfried et al., 2002; Versteeg et al., 2003) .
For these reasons, we have developed a method that accounts for variation in the distance between consecutive genes, gene density, and GC content to identify extreme chromosomal regions of gene expression (E-CHaRGE). We demonstrate the method by applying it to a breast cancer dataset (Pollack et al., 2002) to assess the correspondence between increased and decreased E-CHaRGEs (I-and D-CHaRGEs, respectively) and measured DNA copy number.
Finally, we demonstrate the ability of I-CHaRGEs to predict chromosomal regions containing gene amplification via a logistic regression model.
System and Methods

Scan statistic methodology
The model-based scan statistic developed here expands upon the method developed by Wagner (Wagner, 1999) and is influenced by the landmark paper in this area of scan statistic research by Dembo and Karlin (Dembo & Karlin, 1992) . Without loss of generality, the method is outlined for the analysis of gene expression profiles. Briefly, the scan statistic for gene expression patterns uses two data types -base pair gene position and gene expression level. For a significant I-or D-CHaRGE to be detected, there must be statistical evidence of both a spatial clustering of genes and a clustering of similar gene expression levels (i.e. either above or below a certain threshold for the respective E-CHaRGE) in that cluster of genes. A simple Poisson Process model can be used to detect spatial clusters of genes on a chromosome, but a compound Poisson Process model is necessary to incorporate the gene expression data. A further extension to the compound Poisson Process model is developed below to incorporate variation in gene density, conditional on GC content, into the final model-based scan statistic.
A scan statistic for gene clustering using a simple Poisson Process
A simple Poisson Process is a counting process denoted by {N(t), t 0}, where N(t) is a count of the number of events that occur in some time or space of length t. To identify clusters of genes on a chromosome (ignoring expression levels), the occurrence of a gene on the chromosome is considered to be the event of interest, and N(t) is the number of genes which occur over a given base pair length t on a chromosome described by a single parameter, g , which is the rate of occurrence of genes over a distance of t base pairs (i.e. N(t)/t). The expected number of genes, E[N(t)], over a given base pair length t is equal to g t. For a given group of N(t) genes, we can test the null hypothesis that the N(t) = E[N(t)] against the alternative that N(t) > E[N(t)]. Rejecting the null in favor of the alternative would be consistent with a particular group of genes being identified as a significant cluster.
Reformulating this Poisson Process in terms of a scan statistic, we consider the r distances between the N(t) = r + 1 genes, where r represents the number of intervals between N(t) genes.
Let X i represent the position of the i-th gene on a chromosome (i =1,…,n= total # of genes on the chromosome) , then the distance between gene i and gene i + 1 can be described as
For a group of r + 1 genes, the distance from gene i to gene i + r may be expressed as the sum of the r distances, S i,r , between these r + 1 genes -that is,
. Since {N(t), t 0} is a simple Poisson Process, the Y i 's are independent and identically distributed as exponential random variables with parameter g , and S i,r is distributed as a gamma random variable with rate parameter g , scale parameter r, and density as follows:
where (r) is the gamma function-that is, (r) = (r -1)! . This density allows one to compute the probability of a cluster of r + 1 genes over a base pair distance of S i,r . Specifically, the probability of observing a cluster of r + 1 genes over a base pair distance as short or shorter than the observed value of S i,r is computed from the density f(s i,r ) as follows:
One can then evaluate the statistical significance of the calculated probability by comparing it to some previously determined -level (e.g. =0.05). If the observed probability is smaller than this selected -level, then the group of genes is identified as a significant gene cluster.
A scan statistic for detecting I-CHaRGEs
To incorporate gene expression data into this scan statistic framework to identify I-CHaRGEs, we consider the original Poisson Process describing genes on chromosomes {N(t), t 0} to be partitioned into two independent Poisson Processes: one for genes exceeding a particular 
Based on these two independent Poisson Processes, we define the compound Poisson Process, {U(t), t 0}, for identifying I-CHaRGEs. U(t) is a sum of the independent and identically distributed I i 's for a given tumor, defined as
. As one can see, U(t) counts the number of genes that are increased above the set threshold over a base pair distance t containing a total of N(t) genes.
The base pair width of that cluster in a particular tumor is then represented by
and is used to calculate the probability of an increased expression cluster based on the gamma density as follows:
where k (similar to r above) is the number of intervals between U(t) increased expression genes.
In the case where U(t) = N(t) (i.e. all genes observed over a base pair distance of size t are increased), k = r and the probability calculation is virtually identical to the probability calculated using equation (1), with the exception of substituting 1 for g . The case where k < r correspond to less than all of the genes in a region being over-expressed.
For the detection of D-CHaRGEs, the method described here for the detection I-CHaRGEs may be applied reciprocally.
A model-based scan statistic conditional upon gene density and GC content
Up to this point, we have assumed a single genomic rate parameter, g , to determine the probability of observing a particular I-CHaRGE. Using a single genomic rate parameter will underestimate the probability of a cluster in gene dense regions (where the distance between genes is smaller on average) and overestimate the probability in gene poor regions (where the distance between genes is larger on average). By estimating g based on its position in the genome, i , we can account for variation in gene density by modeling gene occurrence throughout the genome as an "inhomogeneous" compound Poisson Process (Ross, 1996) and simply replacing 1 with 1i = i p 1 in equation (2) above. The complication lies in the estimation of the i 's.
A primary issue in the estimation of the i 's is that they must be on a scale determined by the array-based map to ultimately generate appropriate E-CHaRGE probability estimates. For this reason, the initial estimates of the i 's will be generated directly from the array-based map.
However, these estimates of gene density are subject to error due to the gene sampling strategy used in the design of a particular microarray. For example, a gene rich portion of the genome might be under-sampled on a particular array, and the resulting i for that region may be underestimated. To account for a portion of this error, we propose conditioning of the initial estimates of the i 's based on local genomic GC content.
Using GC content has a number of appealing characteristics. First, GC content has long been shown to correlate closely with gene density (Bernardi, 2000) . This has been corroborated in recent papers that also explore gene expression in the chromosomal context (Caron et al., 2001; Versteeg et al., 2003) . Further, GC content is the sole parameter used by the gene prediction program GENSCAN (Burge & Karlin, 1997) to determine the expected rate of gene occurrence for an input sequence (i.e. gene density), which is also modeled by GENSCAN as an exponential random variable. Finally, the human genome sequence is readily available, and thus, information on GC content is known and complete.
We utilized a two-stage linear modeling strategy to estimate the i 's. In the first stage, we generate estimates of the i 's based on the average distances between genes on the array-based map. Because the rate parameter is estimated as the inverse of the average distance between two genes, it is impossible to estimate unique i 's for each gene i on the map. Therefore, we propose the division of the genome into bins of equal length (e.g. 10Mb), where the gene's that fall within a particular bin j (j =1,…, n bins = total # of 10 Mb bins) share the same rate parameter j (number of genes per base pair). Summing the distances between adjacent genes within the j th bin and dividing it by the number of such distances gives us the average distance between genes in the j th bin, which is equal to an estimate of j 1 as follows:
where n j is the number of genes in the j th bin, j is the index for the first gene in the j th bin, and y i is the distance between gene i and gene i+1, as above. In the second stage, we model the j 's as a function of GC content for each bin j, x GC,j , using the following linear model:
Therefore, to estimate the probability of an E-CHaRGE within the j th bin conditional on gene density and GC content, the predicted values from this model, multiplied by p 1 , can then be substituted into equation (2). If a potential E-CHaRGE spans more than a single bin, a weighted average of the predicted rate measures from each bin would be an appropriate rate parameter estimate, where the weights would correspond to the number of genes in the potential ECHaRGE from each bin. A weighted average would smooth the transition of the rate parameter between bins and reduce the possibility of biased probabilities due to edge effects.
Results
Map construction and data preparation
Genome-wide DNA copy-number variation and gene expression level data measured in a series of primary human breast carcinomas (n=37) by Pollack et al. (2002) was downloaded from the Supplemental Materials section of the PNAS website for this paper. The dataset consisted of log 2 ratio (tumor/normal) measurements for 6095 UNIGENE clusters, referred to henceforth as "genes". To fill in the missing values in both the aCGH (array comparative genomic hybridization) copy number and expression datasets, we used a k nearest-neighbors algorithm for imputation (Troyanskaya et al., 2001) . As suggested in the manuscript describing this algorithm (Troyanskaya et al., 2001) , an intermediate (10 k 20) value of k = 15 was employed.
The chromosomal map of the genes was created by aligning the 6095 cDNA sequences (downloaded from GenBank) to the human genome (build #34) using the Blast-like alignment tool (Kent, 2002) One of the assumptions of the Poisson Process model is that the distances between genes are distributed as independent and identical exponential random variables. As can be seen from the QQ-plot in figure 1A , the distribution of the base pair distances between these 5883 genes deviated from the expected exponential distribution (i.e. it was right skewed). By employing a square root transformation of distances, the approximation to an exponential distribution was greatly improved (figure 1B).
For each of 5883 genes of the array-based map, GC content was determined using annotation from the University of California at Santa Cruz Genome Browser (http://genome.ucsc.edu). For non-overlapping 20kb regions across the genome, GC percent is estimated as the average number of G and C bases per 1000 base pairs over the 20kb region ("gcPercent" file in the annotation database). Each gene was then assigned the GC content value of the 20kb region within which it aligned. After the division of the genome into 10Mb bins (n=299), the GC content for each bin was determined by averaging the GC content of each gene within the bin . A table describing each of the 10Mb bins (number of genes, base pair boundaries, and average GC content) and the results of the two-stage linear modeling procedure to estimate the bin specific rate parameters is provided as supplemental data.
The model-based scan statistic results
The model-based scan statistic was applied to the genome-wide expression data for each of the 37 primary breast tumors using a standardized mRNA threshold value of 1.65 (+ for ICHaRGEs and -for D-CHaRGEs), and statistically significant E-CHaRGEs were determined using a significance level = 0.01. Using these criteria, a total of 377 I-CHaRGEs and 165 DCHaRGEs were identified among the 217,671 expression measurements (5883 genes multiplied by 37 tumors). The relationship between these E-CHaRGEs and the smoothed DNA copy number measurements within them is displayed in table 1.
We have used the DNA ratio ranges of Pollack et. al. (Pollack et al., 2002) to classify the 217,671 aCGH copy number measurements into the following qualitative copy number catergories: deletion = DNA ratio < 0.8; normal = 0.8 DNA ratio < 1.2; low amplification = 1.2 DNA ratio < 2.0; medium amplification = 2.0 DNA ratio < 3.0; and high amplification = DNA ratio > 3.0. In table 1 To formally explore the association between I-CHaRGE characteristics and whether or not an I-CHaRGE is an AMP I-CHaRGE, we built a logistic regression AMP I-CHaRGE classifier.
Using a stepwise variable selection procedure, the best logistic regression model was determined based on the Akaike information criteria (AIC). The final model contained the number of genes, mean expression, and min expression characteristics. This AMP I-CHaRGE classifier is displayed in table 2.
As can be seen from the parameter estimates (table 2) , both the number of genes and the mean expression of an I-CHaRGE have a positive association with the probability of being an AMP I-CHaRGE, while min expression is negatively associated. Therefore, the pattern of I-CHaRGE characteristics that distinguishes AMP I-CHaRGEs from s CHaRGE I AMP is that AMP ICHaRGEs contain more genes, have a higher mean expression value, and may possess at least one gene with very low expression relative to other tumors.
Using a predicted probability > 0.65 for identifying an AMP I-CHaRGE, we validated this model using a 10-fold cross validation procedure (table 3) We also explored the effect of altering the expression threshold and -level used to identify ICHaRGEs on the performance of the AMP I-CHaRGE classifier (table 3) . In general, there was a high degree of similarity among each classification measure across expression threshold andlevel combinations. The predictive value positive measures were generally high, with a median value of 0.81 and a range from 0.75 to 0.89. Similarly, the specificity measures were also high, with a median value of 1.00 and a range from 0.97 to 1.00. The sensitivity measures were lower, with a median value of 0.25 and a range from 0.16 to 0.41. This overall similarity of classification measures suggests that the AMP I-CHaRGE classifier is robust to alterations in the expression threshold and -level used to identify I-CHaRGEs.
Discussion
Our model-based scan statistic represents a significant advancement in methods to detect chromosomal patterns of gene expression. With the incorporation of the distances between genes and variation in gene density conditional upon GC content, we have accounted for genomic complexity that will result in more precise estimation of E-CHaRGE probabilities and corresponds to the spatial nature of DNA amplification, one mechanism that may account for ICHaRGEs. In our application to data from a breast cancer study where gene expression and DNA copy number were measured in parallel (Pollack et al., 2002) , notable features underlying the relationship between gene expression and gene amplification were revealed. Generally, many I-CHARGEs were associated with multiple contiguous gene amplifications. Such ICHaRGEs were not restricted to one chromosome or tumor, but rather, they were spread throughout the genomes of all 37 tumors studied. Further, a majority of medium to high copy number amplifications was associated with I-CHaRGEs, which we termed AMP I-CHaRGEs.
These results indicate a regional impact of amplification on gene expression that may be captured through a method such as the model-based scan statistic, which allows for the inclusion of important genomic features (e.g GC content) related to amplification.
A major advantage of our model-based scan statistic is that inferences are made for each chromosomal region of each individual tumor rather than being restricted to inferences on collections of tumors (Caron et al., 2001; Zhou et al., 2003) . Using all I-CHaRGEs identified in each tumor, we were able to demonstrate that individual attributes of I-CHaRGEs (number of genes, mean expression, and min expression) could be used to accurately predict AMP ICHaRGEs. While other studies have demonstrated that increased regions of gene expression correspond to confirmed cancer-specific regions of recurrent amplification (Crawley & Furge, 2002; Zhou et al., 2003) , this is the first demonstration that the expression data may be used by itself to predict gene amplification in the tumors under study. This suggests that microarray gene expression data and the model-based scan statistic may be used together to target particular tumors for molecular genetic studies to identify new amplicons.
In addition to its prediction accuracy, the AMP I-CHaRGE classification model also reflects a pattern of expression corresponding to putative amplicons where the majority of genes have increased expression but one or more may have very low expression. This model reflects the results of studies of gene expression within identified amplicons in a variety of primary human tumors (Bayani et al., 2002; Hyman et al., 2002; Linn et al., 2003; Pollack et al., 2002; Wolf et al., 2004) , which suggest that this situation is more likely to be the rule than the exception.
However, the relatively low sensitivity estimates of this model suggest that improvements in the classification of AMP I-CHaRGEs can be made. For instance, the use of more sophisticated classification methodology (e.g. neural networks, classification trees, ect.) that exploit other features of the regional expression pattern may lead to improved sensitivity and potentially increase our understanding about patterns of gene expression within medium to high copy number amplicons.
In comparison to previous methods to detect chromosomal patterns of gene expression, the model-based scan statistic approach has the advantage of being parametric. Thus, the statistical significance of an E-CHaRGE is determined in comparison to a theoretical null distribution rather than having to estimate it using permutation strategies where the results are data dependent
and cannot be easily compared across different data sets. A downside to the parametric nature of the method is that the required gene expression standardization restricts inferences about increased and decreased expression relative to the mean of the tumor sample under study. This situation will make it impossible to identify the case where a majority of tumors have an identical E-CHaRGE. While this fault is non-trivial, we expect this situation to be exceedingly rare, as there was no single gene in the breast cancer dataset where a majority of tumors were either two-fold over-or under-expressed relative to normal tissue. Further, standardization allows for the application of this methodology to tumor sets where normal tissue controls are unavailable for study.
There are important features that must be addressed before utilizing the model-based scan statistic. First, for the Poisson Process model to be appropriate, the distances between events must be exponentially distributed or transformed to approximate that distribution. With the increasing number of genes measured on expression arrays, deviations from the underlying exponential distribution are expected to be less extreme. Next, under the Poisson Process model, the assumption is made that the lengths of genes are negligible in comparison to the distances between them. Given the large ratio of non-coding to coding DNA in the genome, this assumption is typically valid. However, in some areas of the genome, extremely large genes may violate this assumption, resulting in distorted probability estimates. Finally, we chose to use gene density estimates based on the array-based map, and to account for a portion of the error in these estimates, we conditioned them on GC content to incorporate a varying rate parameter into the model-based scan statistic. In our application, we estimated the rate parameter for 10Mb
bins. Alteration of the bin size from 2-20 Mbs had little impact upon the E-CHaRGEs identified (data not shown). GC content, however, is just one genomic covariate that has been shown to be associated with gene density. As more is known about the actual gene distribution of the genome, this knowledge can be readily incorporated in this methodology. a I-and D-CHaRGEs were identified using an standardized expression threshold of Z > |1.65| and = 0.01. b DNA copy number ratio ranges were determined in the original article (Pollack et al., 2002) presenting this data. c A total of 217,671 DNA ratio measurements (5883 cDNA probes measured for 37 primary breast tumors) were used for this analysis. d A total of 377 I-CHaRGEs were identified within these 37 tumors, which covered a total of 2130 DNA measurements. e A total of 165 D-CHaRGEs were identified within these 37 tumors, which covered a total of 868 DNA measurements. a An AMP I-CHaRGE is defined as an I-CHaRGE (Z > 1.65 and = 0.01) that is associated with medium to high copy number amplification (at least one DNA copy number ratio > 2). b The final variables for the logistic regression model AMP I-CHaRGE classifier were selected from the following I-CHaRGE characteristics: number of genes, median expression, mean expression, maximum expression, and minimum expression. A stepwise procedure was used to select the final variables for the model. c The intercept term in the logistic regression model does not have an odds ratio interpretation. Therefore, this field and those to its right contain a "-". a All I-CHaRGEs identified (for each expression threshold and -level combination) were divided into ten approximately equal groups. For each of ten rounds, one of the ten groups was held out, and the remaining nine tenths of the data was used to estimate the classifier. The estimated classifier was then applied to the held out I-CHaRGEs to estimate their predicted probabilities. If the predicted probability was > 0.65, the I-CHaRGE was classified as an AMP I-CHaRGE. Those I-CHaRGEs with a predicted probability 0.65 were classified as CHaRGE I AMP . b AMP = amplification, where amplification is defined as a DNA ratio measurement > 2. c AMP = not amplified, where a DNA ratio measurement 2. d PVP = predictive value positive of the AMP I-CHaRGE classifier. PVP is equal to the probability of that an AMP I-CHaRGE is correctly identified and does contain DNA amplification. e FDR = false discovery rate of the classifier. FDR is equal to 1 -PVP, which is equal to the probability that an AMP I-CHaRGE is falsely identified and does not contain DNA amplification. f SEN = sensitivity of the classifier. SEN is equal to the probability that an I-CHaRGE in a region of amplification is correctly classified as an AMP I-CHaRGE. g SPEC = specificity of the classifier. SPEC is equal to the probability that an I-CHaRGE in a region that is not amplified is correctly classified as CHaRGE I AMP .
Figure 1: QQ-plots comparing distance between genes distributions to randomly drawn exponential distributions.
A) The distribution of the 5860 base pair distances between adjacent genes spread throughout the genome (excluding chromosome Y) is compared to a randomly drawn exponential distribution, with a rate parameter equal to 2.01e-06. The rate parameter is calculated as the inverse of the mean base pair distance between genes, which is equal to 496,892 bp. The dashed line drawn on the plot has an intercept = 0 and slope = 1. Deviation from this 45º line indicates deviation from the expected exponential distribution. B) The distribution of the 5860 square root base pair distances between adjacent genes is compared to a randomly drawn exponential distribution, with a rate parameter equal to 0.0018 (the inverse of the mean of the 5850 square root distances between genes = 542.77).
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